Literature DB >> 25932801

C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies.

Tian Xu1, Kaifu Ke2.   

Abstract

Entities:  

Keywords:  C-reactive protein; Dose–response meta-analysis; Ischemic stroke; Prospective studies

Mesh：

Substances：

Year:  2015        PMID： 25932801     DOI： 10.1016/j.ijcard.2015.04.176

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Identification of Functional Genetic Polymorphisms at IL-10 Promoter Region and their Association with Risk of Ischemic Stroke in Chinese Han Population.

Authors:  Y Tong; S Jiang; L Cai; X Guan; S Hou; Z Wang; Q Lu; J Liu
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 2.  Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies.

Authors:  Xingjin Yang; Dongdong Zhang; Yang Zhao; Dechen Liu; Quanman Li; Chunmei Guo; Gang Tian; Minghui Han; Ranran Qie; Shengbing Huang; Qionggui Zhou; Yang Zhao; Yifei Feng; Xiaoyan Wu; Yanyan Zhang; Yang Li; Yuying Wu; Cheng Cheng; Dongsheng Hu; Liang Sun
Journal:  J Hum Hypertens       Date:  2021-05-12       Impact factor: 3.012

3.  The PAr index, an indicator reflecting altered vitamin B-6 homeostasis, is associated with long-term risk of stroke in the general population: the Hordaland Health Study (HUSK).

Authors:  Hui Zuo; Grethe S Tell; Per M Ueland; Ottar Nygård; Stein E Vollset; Øivind Midttun; Klaus Meyer; Arve Ulvik
Journal:  Am J Clin Nutr       Date:  2018-01-01       Impact factor: 7.045

Review 4.  Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies.

Authors:  Georgios Markozannes; Charalampia Koutsioumpa; Sofia Cividini; Grace Monori; Konstantinos K Tsilidis; Nikolaos Kretsavos; Evropi Theodoratou; Dipender Gill; John Pa Ioannidis; Ioanna Tzoulaki
Journal:  Eur J Epidemiol       Date:  2020-09-25       Impact factor: 8.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.